See recent publication in Cell regarding a second Delix Therapeutics psychoplastogen.

Delix logo

Rewiring the Brain to Heal the Mind.

Our Mission

Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.

Publications Related to Our Technologies

ACS Pharmacology & Translational Science
Journal of Medicinal Chemistry
ACS Chemical Neuroscience
Journal of Experimental Neuroscience
ACS Chemical Neuroscience
Cell Reports


To reach us, email: